Eagle Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.87M | Sell |
|
|||||
|
2022
Q3 | $3.36M | Buy |
|
|||||
|
2022
Q2 | $3.06M | Sell |
|
|||||
|
2022
Q1 | $7.69M | Sell |
|
|||||
|
2021
Q4 | $8.81M | Buy |
|
|||||
|
2021
Q3 | $7.57M | Sell |
|
|||||
|
2021
Q2 | $9.9M | Sell |
|
|||||
|
2021
Q1 | $41.7M | Sell |
|
|||||
|
2020
Q4 | $50.9M | Buy |
|
|||||
|
2020
Q3 | $59.1M | Buy |
|
|||||
|
2020
Q2 | $40.8M | Buy |
|
|||||
|
2020
Q1 | $13.5M | Sell |
|
|||||
|
2019
Q4 | $15.3M | Sell |
|
|||||
|
2019
Q3 | $16.3M | Buy |
|
|||||
|
2019
Q2 | $14.8M | Buy |
|
|||||
|
2019
Q1 | $10.6M | Buy |
|
|||||
|
2018
Q4 | $10.7M | Buy |
|
|||||
|
2018
Q3 | $9.63M | Sell |
|
|||||
|
2018
Q2 | $7.48M | Sell |
|
|||||
|
2018
Q1 | $8.39M | Buy |
|
|||||
|
2017
Q4 | $6.67M | Sell |
|
|||||
|
2017
Q3 | $10.5M | Buy |
|
|||||
|
2017
Q2 | $8.43M | Buy |
|
|||||
|
2017
Q1 | $6.89M | Sell |
|
|||||
|
2016
Q4 | $8.01M | Buy |
|
|||||
|
2016
Q3 | $7.57M | Sell |
|
|||||
|
2016
Q2 | $11.7M | Sell |
|
|||||
|
2016
Q1 | $15.2M | Sell |
|
|||||
|
2015
Q4 | $17M | Sell |
|
|||||
|
2015
Q3 | $17.7M | Buy |
|
|||||
|
2015
Q2 | $16.8M | Buy |
|
|||||
|
2015
Q1 | $8.17M | Buy |
|
|||||
|
2014
Q4 | $7.54M | Buy |
|